Literature DB >> 17942973

NF45 and NF90 in murine seminiferous epithelium: potential role in SP-10 gene transcription.

Sandeep A Ranpura1, Umesh Deshmukh, Prabhakara P Reddi.   

Abstract

Identification of transcription factors involved in the progression of spermatogenic cell differentiation is important for understanding the molecular mechanisms controlling spermatogenesis. To this end, we utilized the mouse SP-10 gene encoding a conserved acrosomal protein as an experimental model. Promoter analysis in transgenic mice had previously shown that the -186/-91 region of the SP-10 promoter was critical for spermatid-specific expression. Here, we focus on a purine (Pu) box (-agaaaa) located at -154, which is conserved in the mouse, monkey, and human SP-10 gene promoters. NF45 and NF90, which belong to the family of nuclear factor of activated T cells (NFAT), are known as Pu-box-binding proteins. We tested the potential of NF45 and NF90 to activate the SP-10 promoter via the Pu-box element. Immunohistochemistry showed the presence of NF45 and NF90 in the nuclei of pachytene spermatocytes, round spermatids, and Sertoli cells. In gel shift assays, recombinant NF45 bound to the mouse SP-10 promoter in an AGAAAA site-specific manner. Cotransfection of NF45 and NF90 up-regulated SP-10 promoter-driven luciferase expression in transiently transfected spermatogenic GC2 cell line; this up-regulation required the -AGAAAA- site. Furthermore, stimulation of the endogenous NF45-NF90 complex in Jurkat cells by phorbol myristate acetate + ionomycin up-regulated the SP-10 promoter activity in plasmid-based assays. In the context of chromatin, however, stimulation of NF45-NF90 alone was not sufficient to activate an SP-10 promoter-driven green fluorescent protein transgene. Based on these results, we propose that NF45 and NF90 have the potential to activate SP-10 gene transcription, and that a chromatin modification event must occur first in order to provide access to these transcription factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942973     DOI: 10.2164/jandrol.107.003756

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  7 in total

1.  The NF90/NF45 complex participates in DNA break repair via nonhomologous end joining.

Authors:  Raghavendra A Shamanna; Mainul Hoque; Anita Lewis-Antes; Edouard I Azzam; David Lagunoff; Tsafi Pe'ery; Michael B Mathews
Journal:  Mol Cell Biol       Date:  2011-10-03       Impact factor: 4.272

2.  Nuclear factor NF45 interacts with viral proteins of infectious bursal disease virus and inhibits viral replication.

Authors:  Ruth L O Stricker; Sven-Erik Behrens; Egbert Mundt
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90/110 involved in mitotic control.

Authors:  Deyu Guan; Nihal Altan-Bonnet; Andrew M Parrott; Cindy J Arrigo; Quan Li; Mohammed Khaleduzzaman; Hong Li; Chee-Gun Lee; Tsafi Pe'ery; Michael B Mathews
Journal:  Mol Cell Biol       Date:  2008-05-05       Impact factor: 4.272

4.  A novel long intergenic noncoding RNA indispensable for the cleavage of mouse two-cell embryos.

Authors:  Jiaqiang Wang; Xin Li; Leyun Wang; Jingyu Li; Yanhua Zhao; Gerelchimeg Bou; Yufei Li; Guanyi Jiao; Xinghui Shen; Renyue Wei; Shichao Liu; Bingteng Xie; Lei Lei; Wei Li; Qi Zhou; Zhonghua Liu
Journal:  EMBO Rep       Date:  2016-08-05       Impact factor: 8.807

5.  NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response.

Authors:  T E Graber; S D Baird; P N Kao; M B Mathews; M Holcik
Journal:  Cell Death Differ       Date:  2009-11-06       Impact factor: 15.828

Review 6.  NF90 in posttranscriptional gene regulation and microRNA biogenesis.

Authors:  Kiyoshi Masuda; Yuki Kuwano; Kensei Nishida; Kazuhito Rokutan; Issei Imoto
Journal:  Int J Mol Sci       Date:  2013-08-19       Impact factor: 5.923

7.  Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells.

Authors:  R A Shamanna; M Hoque; T Pe'ery; M B Mathews
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.